Eczema (Atopic Dermatitis - Pediatric) Clinical Trials

A listing of Eczema (Atopic Dermatitis - Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 19 clinical trials
Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis

The purpose of the study is to compare the efficacy and safety of benralizumab versus placebo and to compare benralizumab dosing regimens during extension period.

follicle stimulating hormone
hysterectomy
topical agents
  • 0 views
  • 01 Aug, 2021
  • 62 locations
A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

The reason for this study is to see if the study drug called baricitinib works and is safe in children and teenage participants with atopic dermatitis.

ly3009104
topical corticosteroid
atopy
eczema
corticosteroids
  • 103 views
  • 31 Jul, 2021
  • 190 locations
Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis

This is a research study to determine the efficacy and safety of investigational drug MEDI3506 for the treatment of adult subjects with Atopic Dermatitis.

topical agents
atopy
body mass index
  • 182 views
  • 27 Jul, 2021
  • 58 locations
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

This 110-week study is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis.

progestogen
lebrikizumab
atopy
eczema
hormonal contraception
  • 154 views
  • 31 Jul, 2021
  • 347 locations
Seal Stopping Eczema and Allergy Study

This is a randomized, controlled trial designed for children who are have already developed atopic dermatitis (AD or eczema) by 10 weeks of age. The aim is to compare the effect of proactive sequential skin care, including the twice-daily use of a tri-lipid skin barrier cream (Epiceram) or moisturizer and …

eczema
dry skin
food allergy
epiceram
topical agents
  • 0 views
  • 19 Jul, 2021
  • 3 locations
A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

The purpose of this study is to evaluate the effectiveness and safety of 3 dose regimen of CC-93538 in adult participants with moderate to severe Atopic Dermatitis (AD).

asthma
ultraviolet light
corticosteroids
topical agents
montelukast
  • 0 views
  • 25 Jul, 2021
  • 85 locations
A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.

The main purpose of this phase 2 study is to assess the efficacy and safety of CMK389 in patients with atopic dermatitis.

topical agents
body mass index
  • 0 views
  • 31 Jul, 2021
  • 11 locations
A Study to Test the Safety Pharmacokinetics and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis

The purpose of the study is to investigate the safety and tolerability of single-ascending doses of UCB9741 administered by intravenous infusion or subcutaneous injection to healthy study participants and following repeat dosing at a single dose level in study participants with atopic dermatitis. Furthermore, the clinical outcome in study participants …

eczema
body mass index
  • 0 views
  • 20 Jul, 2021
  • 1 location
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis

This open-label study will evaluate the long-term efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis (AD).

ly3009104
eczema
topical agents
baricitinib
  • 0 views
  • 25 Jul, 2021
  • 76 locations
A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic Dermatitis

The purpose of this study is to evaluate the effect of nemolizumab (CD14152) on the pharmacokinetics (PK) of a drug "cocktail" representative of CYP450 (CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4/5 sensitive index substrates) in adult participants with moderateto- severe atopic dermatitis (AD).

calcineurin inhibitor
topical corticosteroid
eczema
nemolizumab
topical agents
  • 0 views
  • 17 Jul, 2021
  • 7 locations